Silvia Taylor

Silvia Taylor is the executive vice president and chief corporate affairs and advocacy officer at Novavax, a biotechnology company known for its work on vaccines, including its Covid-19 vaccine. Recently, she was in the news discussing the company's response to the FDA's request for additional trials as part of the post-marketing commitment for the Covid-19 vaccine, which is currently under review for full approval.